W. Dominika Wranik

Education

• PhD (University of Manitoba)

Research Interests

Dr. Wranik’s research interests revolve around the design of financing models, governance models, policies and processes that best support Canadian health care goals. Examples include her work on remuneration and managerial governance of primary health care teams, or her work on developing clear processes for the review of evidence in drug funding decisions. She works in close collaboration with academic researchers and health care decision makers across Canada, currently including Alberta Health, Manitoba Health, Nova Scotia Department of Health and Wellness, and the pan-Canadian Oncology Drug Review.

Selected Awards and Honours

• National Science Centre (Poland) – POLONEZ3 Research Fellowship ($136,000) – Study title: Evidence use in the allocation of health care budgets: A comparative study of drug reimbursement in Poland, Canada, and Germany
  
• CIHR – Knowledge Synthesis Grant ($100,000) – Study title: How best to structure interdisciplinary primary care teams: A systematic review
  
• NSHRF – Catalyst Award ($10,000) – Project title: Expanding the scope and team of the study of Canadian Formulary Processes to include International Comparison and Researchers
  
• CIHR – Partnerships in Health Systems Improvement research grant ($369,375). Study title: AFFORD - Appropriate effective efficient Oncology Reimbursement Decisions
• CIHR – Healthcare Renewal Policy Analysis research grant ($135,203) Study title: 3C&Q – Funding interdisciplinary primary health care teams – Collaboration, Coordination, Comprehensiveness and Quality

Selected Publications

• The relative importance of clinical, economic, patient values and feasibility criteria in Cancer Drug Reimbursement in Canada: A revealed preferences analysis of recommendations of the pan-Canadian Oncology Drug Review 2011-2017. Skedgel, C., Wranik, W.D. & Hu, M. Pharmacoeconomics. First Online (2018)
• Funding and remuneration of interdisciplinary primary care teams in Canada: A conceptual framework and application. Wranik, W.D., Haydt, S.M., Katz, A., Levy, A.R., Korchagina, M., Edwards, J.M. & Bower, I. BMC Health Services Research 17:351  (2017)
  
• Costs of productivity loss due to occupational cancer in Canada: Estimation using claims data from Workers' Compensation Boards. Wranik, D., Muir, A. & Hu, M. Health Economics Review 7(9)  (2017)
• How best to structure interdisciplinary primary care teams: the study protocol for a systematic review with narrative framework synthesis. Wranik, D., Hayden, J.A., Price, S., Parker, R.N., Haydt, S.M., Edwards, J.M., Suter, E., Katz, A., Gambold, L.L. & Levy, A.R. Systematic Reviews 5:170  (2016)
  
• The evolution of the cancer formulary review in Canada: Can centralization improve the use of economic evaluation? Wranik, D., Gambold, L., Hanson, N. & Levy, A. International Journal of Health Planning and Management (online view)  (2016)

Current Teaching

• PUAD 5130 - Managerial Economics
• PUAD 6450 - Economics of Health Policy